<DOC>
	<DOCNO>NCT02485743</DOCNO>
	<brief_summary>This multi-centre , randomise control trial conduct 24-weeks evaluate effect healthy diet supplement product specifically develop ( SATIN satiety product ) enhance feeling satiety reduce food intake initial weight loss period assess weight maintenance . Participants either receive active SATIN product match control product . The product contain ingredient show positively affect satiety , satiation and/or body weight accept food ingredient approve human consumption Europe . They incorporate different food matrix , e.g . drink , shake cheese . Corresponding control product without active ingredient provide participant allocate control group . The participant instruct detail consume test product . Participants 300 adult ( BMI &gt; 27kg/m2 ; Age &gt; 18years ) test three research site ( University Liverpool , United Kingdom ; University Copenhagen , Denmark University Rovira I Virgili , Spain ) . Recruitment divide site . Participants attend assessment one three research sit continually throughout study period . The primary outcome weight maintenance low calorie diet assess weight , waist circumference , body composition ( DXA ) , energy intake subjective appetite assessment make study test session . Secondary outcome include assess biomarkers health outcome ( blood urine index ) , change physical activity well consumer benefit trial ( assessed range questionnaire ) determine diet efficacy .</brief_summary>
	<brief_title>A Trial Comparing Diet Including Products Aimed Targeting Satiety</brief_title>
	<detailed_description>The study double blind parallel randomize multicentre study , six arm . The study conduct simultaneously Denmark , Spain United Kingdom , study site specify page 3 . A total 300 participant initial BMI 27 35 kg/m2 fat mass le 23 % enrol study . An initial weight loss minimum 8 % need inclusion randomize part study . The weight loss achieve administration low calorie diet ( LCD ) 8 week manage dietician supervise group session . Failure reach least 8 % weight reduction LCD result exclusion intervention . Participants reach pre-defined weight loss le 8 % enter 7-10 day run-in period diet stabilization enter 12-week randomize part study . In randomized part study participant advise follow general healthy weight loss maintenance diet accordance national dietary guideline . In addition , participant randomly allocate 1:1 ratio one follow intervention group ; 1 ) include active satiety enhance product ( active intervention group ) 2 ) include similar control product without satiety enhance property ( control group ) . For group , participant instruct consume intervention product daily . Primary study visit assessment body weight , waist circumference , hip circumference , sagittal diameter blood pressure perform beginning , end intervention period . At least every four week intervention , participant request pick study product , visit bodyweight waist hip circumference record . The participant furthermore meet individually dietician three time 12 week intervention period enhance compliance weight loss maintenance diet ensure incorporation study specific product diet instructed . Adverse event concomitant medicine register continuously throughout study . For participant , total study duration 24 week , include 17 visit study site total ( 14+3 appetite probe day )</detailed_description>
	<criteria>BMI ≥ 27,0 ≤ 35,0 kg/m2 Fat mass ≥ 23 % assessed bio impedance screen visit Healthy Acceptance experimental food Provided voluntary write informed consent &lt; 8.0 % weight loss Low Calorie Diet ( LCD ) period ( assessed visit 7 complete 8 week LCD period ) Dislike ≥ 25 % study product ( assessed visit 7 test tasting ) Known disease may affect energy expenditure and/or satiation/satiety/food intake i.e . inflammatory bowel disease , thyroid decease , major depression bipolar decease Eating behaviour characteristic ( e.g . restrain eating , disinhibition , emotional eating ) identify screen visit base questionnaire Weight change ±3 kg last three month Dietary pattern interfere study protocol , judge Investigator ( e.g . vegetarian , vegan , low carb dieter , high fat dieter ) two month prior inclusion , study plan initiate study Severe food allergy food intolerance expect interfere study Engagement elite sport similar strenuous exercise ≥ 5h/week Pregnancy lactation , pregnancy within past 12 month plan become pregnant study Smoking , smoke cessation within past three month and/or nicotine use ( include electronic cigarette ) Medical condition know participant : Diabetes mellitus ( type 1 2 ) ( History gestational diabetes mellitus allow ) Cardiovascular disease include current angina ; myocardial infarction ; coronary revascularization procedure ; stroke ( either ischemic hemorrhagic , include transient ischemic attack ) ; symptomatic peripheral artery disease require surgery diagnose vascular imaging technique ; ventricular arrhythmia ; uncontrolled atrial fibrillation ; congestive heart failure ( New York Heart Association Class II IV ) ; hypertrophic myocardiopathy ; history aortic aneurism ≥5.5 cm diameter aortic aneurism surgery within past six month , diagnose medical doctor Systolic blood pressure 160 mmHg and/or diastolic blood pressure 100 mmHg whether treatment hypertension . If treat , stable treatment ( i.e . change treatment , either dose , type medication change ) within last 3 month require Chronic kidney disease define either kidney damage estimate Glomerular Filtration Rate ( eGFR ) less 60 mL/min/1.73m2 Creatinine &gt; 1.5 time upper limit normal ( accord local laboratory reference value ) longer 3 month diagnose medical doctor Liver disease e.g . cirrhosis ( fatty liver disease allow ) , liver dysfunction transaminase ( Alanine Transaminase ( ALT ) and/or Aspartate Transaminase ( ASAT ) ) 3 time upper limit normal ( accord local laboratory reference value ) diagnose medical doctor Active inflammatory bowel disease , celiac disease , chronic pancreatitis disorder potentially cause malabsorption Cancer active malignant cancer history malignancy within last 5 year ( exception local basal squamous cell skin cancer ) . Previous bariatric surgery intention undergo bariatric surgery within next 12 month History extensive small large bowel resection Known endocrine origin obesity ( except treat hypothyroidism ) Transmissible bloodborne diseases e.g . hepatitis B , HIV Any recent surgical procedure fully recover ( judged investigator ) Current use prescription medication use within previous month potential affect body weight systemic corticosteroid ( exclude inhale topical steroid ) psychoactive medication , epileptic medication , weight loss medication ( either prescription , counter herbal ) . Low dose antidepressant allow , judgment investigator , affect body weight participation study protocol . Levothyroxine treatment hypothyroidism allow participant stable dose least 3 month Current use prescription medication affect body weight stable past 3 month expect stable study Concurrent therapy immunosuppressive drug cytotoxic agent Haemoglobin concentration local laboratory reference value ( i.e . anaemia ) Blood donation transfusion within past month screen study Regularly consumption alcohol recommendation ; &gt; 21 alcoholic units/week ( men ) , &gt; 14 alcoholic units/week ( woman ) Drug abuse , judge investigator , within previous 12 month Psychological behavioural problem , judgement investigator , would lead difficulty comply study protocol Psychiatric disorder : schizophrenia , bipolar disease , eat disorder , depression hospitalization within last 6 month . Participation clinical trial within past three month intention study , likely affect present study History repeat failure complete LCD Allergy intolerance component LCD product Unable follow recommend diet religious reason , swallow disorder , physiological reason reason able follow recommend diet Inability unwillingness give write informed consent communicate study personnel Inability unwillingness follow study protocol instruction give study personnel Institutionalization permanent longstay resident care home similar institution Illiteracy Any condition judge investigator may interfere adherence study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>satiation</keyword>
	<keyword>satiety</keyword>
	<keyword>weight loss</keyword>
	<keyword>maintain weight loss</keyword>
</DOC>